Brain-Derived Neurotrophic Factor in Neonatal Seizures

Pediatr Neurol. 2021 May:118:35-39. doi: 10.1016/j.pediatrneurol.2021.01.011. Epub 2021 Feb 5.

Abstract

Brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, has an extensively studied classical role in neuronal growth, differentiation, survival, and plasticity. Neurotrophic, from the Greek neuro and trophos, roughly translates as "vital nutrition for the brain." During development, BDNF and its associated receptor tyrosine receptor kinase B are tightly regulated as they influence the formation and maturation of neuronal synapses. Preclinical research investigating the role of BDNF in neurological disorders has focused on the effects of decreased BDNF expression on the development and maintenance of neuronal synapses. In contrast, heightened BDNF-tyrosine receptor kinase B activity has received less scrutiny for its role in neurological disorders. Recent studies suggest that excessive BDNF-tyrosine receptor kinase B signaling in the developing brain may promote the hyperexcitability that underlies refractory neonatal seizures. This review will critically examine BDNF-tyrosine receptor kinase B signaling in the immature brain, its role in the emergence of refractory neonatal seizures, and the potential of targeting BDNF-TrkB signaling as a novel antiseizure strategy.

Keywords: BDNF; Development; Epilepsy; KCC2; Seizures; TrkB.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Brain-Derived Neurotrophic Factor / physiology*
  • Humans
  • Infant, Newborn
  • Membrane Glycoproteins / physiology
  • Receptor, trkB / physiology
  • Seizures / etiology*
  • Seizures / metabolism
  • Seizures / therapy*
  • Signal Transduction / physiology

Substances

  • Brain-Derived Neurotrophic Factor
  • Membrane Glycoproteins
  • BDNF protein, human
  • Receptor, trkB
  • tropomyosin-related kinase-B, human